RETRACTION: MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC (vol 110, pg 656, 2019)

被引：0

作者：

Quan, Jing ^{[1
,2
,3
]}

Pan, Xiang ^{[1
,2
,3
]}

Li, Yawen ^{[2
,3
]}

Hu, Yimin ^{[1
]}

Tao, Lingzhi ^{[1
]}

Li, Zuwei ^{[1
]}

Zhao, Liwen ^{[1
,2
,3
]}

Wang, Jingyao ^{[1
,3
]}

Li, Hang ^{[1
]}

Lai, Yulin ^{[1
]}

Zhou, Liang ^{[1
]}

Lin, Canbin ^{[1
,3
]}

Gui, Yaoting ^{[3
]}

Ye, Jing ^{[3
]}

Zhang, Fangting ^{[3
]}

Lai, Yongqing ^{[1
,3
]}

机构：

[1] Peking Univ, Shenzhen Hosp, Dept Urol, Shenzhen 518036, Guangdong, Peoples R China

[2] Anhui Med Univ, Hefei 230032, Anhui, Peoples R China

[3] Peking Univ, Shenzhen PKU HKUST Med Ctr, Guangdong & Shenzhen Key Lab Male Reprod Med & Gen, Inst Urol,Shenzhen Hosp, Shenzhen 518036, Guangdong, Peoples R China

来源：

BIOMEDICINE & PHARMACOTHERAPY | 2024年 / 177卷

关键词：

D O I：

10.1016/j.biopha.2024.117098

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页数：1

共 50 条

[1] MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC (vol 110, pg 656, 2019)
Quan, Jing
Pan, Xiang
Li, Yawen
Hu, Yimin
Tao, Lingzhi
Li, Zuwei
Zhao, Liwen
Wang, Jingyao
Li, Hang
Lai, Yulin
Zhou, Liang
Lin, Canbin
Gui, Yaoting
Ye, Jing
Zhang, Fangting
Lai, Yongqing
BIOMEDICINE & PHARMACOTHERAPY, 2019, 112
[2] MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC
Quan, Jing
Pan, Xiang
Li, Yawen
Hu, Yimin
Tao, Lingzhi
Li, Zuwei
Zhao, Liwen
Wang, Jingyao
Li, Hang
Lai, Yulin
Zhou, Liang
Lin, Canbin
Gui, Yaoting
Ye, Jing
Zhang, Fangting
Lai, Yongqing
BIOMEDICINE & PHARMACOTHERAPY, 2019, 110 : 656 - 666
[3] RETRACTION: Long noncoding RNA DARS-AS1 acts as an oncogene by targeting miR-532-3p in ovarian cancer (Retraction of Vol 23, Pg 2353, 2019)
Huang, K.
Fan, W. -S.
Fu, X. -Y.
Li, Y. -L.
Meng, Y. -G.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (13) : 7211 - 7211
[4] RETRACTION: Flot2 targeted by miR449 acts as a prognostic biomarker in glioma (Retraction of Vol 47, Pg 250, 2019)
Huang, Shaosong
Zheng, Shihao
Huang, Shengyue
Cheng, Hui
Lin, Ying
Wen, Yuxing
Lin, Wei
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2021, 49 (01) : 679 - 679
[5] RETRACTION: MiR-532-5p acts as a tumor suppressor and inhibits glioma cell proliferation by targeting CSF1 (Retraction of Vol 23, Pg 8964, 2019)
Wang, Y. -P.
Liu, J.
Liu, D.
Wang, X. -D.
Bian, A. -M.
Fang, D-Z.
Hui, X. -B.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (13) : 7206 - 7206
[6] RETRACTION: LncRNA CASC15 functions as an oncogene by sponging miR-130b-3p in bladder cancer (Retraction of Vol 23, Pg 9814, 2019)
Yu, X.
Wang, Z. -L.
Han, C. -L.
Wang, M. -W.
Jin, Y.
Jin, X. -B.
Xia, Q. -H.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (13) : 7203 - 7203
[7] RETRACTION: CircFBXW7 alleviates glioma progression through regulating miR-23a-3p/PTEN axis (Retraction of Vol 304, Pg 279, 2021)
Gao, Zhi-Gang
Yang, Peng
Huang, Jie
Ding, Yong-Qiang
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 2021, 304 (12): : 2895 - 2895
[8] RETRACTION: LncRNA OTUD6B-AS1 inhibits many cellular processes in colorectal cancer bysponging miR-21-5p and regulating PNRC2 (Retraction of Vol 40, Pg 1463, 2021)
Cai, Y.
Li, Y.
Shi, C.
Zhang, Z.
Xu, J.
Sun, B.
HUMAN & EXPERIMENTAL TOXICOLOGY, 2023, 42
[9] RETRACTION: LncRNA CASC15 promotes migration and invasion in prostate cancer via targeting miR-200a-3p (Retraction of Vol 23, Pg 8303, 2019)
Zhang, C.
Wang, G. -X.
Fu, B.
Zhou, X. -C.
Li, Y.
Li, Y. -Y.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (13) : 7215 - 7215
[10] RETRACTION: HULC functions as an oncogene in ovarian carcinoma cells by negatively modulating miR-125a-3p (Retraction of Vol 75, Pg 163, 2019)
Chu, Ping
Xu, Lina
Su, Haiying
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 2022, 78 (02) : 459 - 459

← 1 2 3 4 5 →